Continuous process improvement can benefit all aspects of life — from personal New Year’s resolutions to complex drug development. In a world where two-thirds of planned improvement initiatives fail, ...
The collaboration marks a turning point in AI-driven drug design and trial forecasting, de-risking the drug development ...
In this interview, NewsMed talks to Dr. James Mencel's Guidance about Scaling Up API Processes. Could you introduce yourself and your experience in the pharmaceutical industry? I obtained a B.S. in ...
Discover how early CMC, process optimization, and formulation strategy drive scalable, commercially viable drugs.
Early-phase clinical trials, those first-in-human studies, are where years of research and millions in investment meet the ...
DynoChem Platform Designed to Facilitate API Process Development and Scale-up Already used by 11 of the world’s biggest pharmaceutical companies, the DynoChem (www.scale-up.com) platform was developed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback